Jessica Tassan
Stock Analyst at Piper Sandler
(0.90)
# 3,699
Out of 4,837 analysts
66
Total ratings
22.64%
Success rate
-11.77%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Jessica Tassan
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CI The Cigna Group | Maintains: Overweight | $348 → $374 | $325.00 | +15.08% | 4 | May 5, 2025 | |
| CVS CVS Health | Maintains: Overweight | $72 → $74 | $63.74 | +16.10% | 5 | Mar 21, 2025 | |
| CTEV Claritev | Maintains: Neutral | $10 → $19 | $28.72 | -33.84% | 1 | Mar 10, 2025 | |
| ALHC Alignment Healthcare | Maintains: Overweight | $14 → $21 | $15.69 | +33.89% | 5 | Mar 4, 2025 | |
| TDOC Teladoc Health | Maintains: Overweight | $13 → $12 | $7.34 | +63.49% | 6 | Feb 27, 2025 | |
| EVH Evolent Health | Reiterates: Overweight | $17 → $16 | $8.77 | +82.44% | 3 | Feb 21, 2025 | |
| HCAT Health Catalyst | Maintains: Overweight | $12 → $8 | $3.94 | +103.05% | 11 | Feb 11, 2025 | |
| PINC Premier | Maintains: Neutral | $21 → $19 | $23.10 | -17.75% | 5 | Feb 5, 2025 | |
| PHR Phreesia | Reiterates: Overweight | $31 → $33 | $25.49 | +29.46% | 5 | Jan 29, 2025 | |
| HUM Humana | Maintains: Neutral | $270 → $288 | $255.31 | +12.80% | 3 | Jan 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $605 → $600 | $321.58 | +86.58% | 5 | Jan 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $28 | $16.47 | +70.01% | 4 | Sep 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $21 → $23 | $53.00 | -56.60% | 3 | Nov 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $66 → $70 | $28.78 | +143.22% | 4 | Aug 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $100 → $70 | $7.55 | +827.15% | 2 | Feb 27, 2023 |
The Cigna Group
May 5, 2025
Maintains: Overweight
Price Target: $348 → $374
Current: $325.00
Upside: +15.08%
CVS Health
Mar 21, 2025
Maintains: Overweight
Price Target: $72 → $74
Current: $63.74
Upside: +16.10%
Claritev
Mar 10, 2025
Maintains: Neutral
Price Target: $10 → $19
Current: $28.72
Upside: -33.84%
Alignment Healthcare
Mar 4, 2025
Maintains: Overweight
Price Target: $14 → $21
Current: $15.69
Upside: +33.89%
Teladoc Health
Feb 27, 2025
Maintains: Overweight
Price Target: $13 → $12
Current: $7.34
Upside: +63.49%
Evolent Health
Feb 21, 2025
Reiterates: Overweight
Price Target: $17 → $16
Current: $8.77
Upside: +82.44%
Health Catalyst
Feb 11, 2025
Maintains: Overweight
Price Target: $12 → $8
Current: $3.94
Upside: +103.05%
Premier
Feb 5, 2025
Maintains: Neutral
Price Target: $21 → $19
Current: $23.10
Upside: -17.75%
Phreesia
Jan 29, 2025
Reiterates: Overweight
Price Target: $31 → $33
Current: $25.49
Upside: +29.46%
Humana
Jan 15, 2025
Maintains: Neutral
Price Target: $270 → $288
Current: $255.31
Upside: +12.80%
Jan 2, 2025
Maintains: Overweight
Price Target: $605 → $600
Current: $321.58
Upside: +86.58%
Sep 10, 2024
Reiterates: Overweight
Price Target: $28
Current: $16.47
Upside: +70.01%
Nov 10, 2023
Maintains: Neutral
Price Target: $21 → $23
Current: $53.00
Upside: -56.60%
Aug 2, 2023
Downgrades: Neutral
Price Target: $66 → $70
Current: $28.78
Upside: +143.22%
Feb 27, 2023
Downgrades: Neutral
Price Target: $100 → $70
Current: $7.55
Upside: +827.15%